Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Chang David D Create: Alert

All | News | Filings
Date FiledTypeDescription
03/24/2023 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 1,924,464 shares @ $0
Granted 1,492,200 options to buy @ $5.04, valued at $7.5M
03/16/2023 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Paid exercise price by delivering 22,340 shares @ $5.56, valued at $124.2k
03/25/2022 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 2,195,512 options to buy @ $9.69, valued at $21.3M
03/17/2022 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 23,648 shares @ $7.6488, valued at $180.9k
05/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2021 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 80,452 shares @ $0
Granted 298,836 options to buy @ $33.78, valued at $10.1M
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2020 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 9,198 shares @ $0
Acquired 9,187 shares @ $0
Gifted 428,022 shares @ $0
Gifted 428,022 shares @ $0
03/20/2020 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 568,600 options to buy @ $18.22, valued at $10.4M
03/18/2020 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 18,710 shares @ $19.2417, valued at $360k
Sold 1,625 shares @ $20.0634, valued at $32.6k
03/11/2020 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 9,402 shares @ $0
Acquired 9,391 shares @ $0
11/21/2019 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 9,402 shares @ $0
Acquired 9,391 shares @ $0
10/29/2019 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 9,402 shares @ $0
Acquired 9,391 shares @ $0
09/25/2019 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 9,402 shares @ $0
Acquired 9,391 shares @ $0
09/09/2019 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 9,402 shares @ $0
Acquired 9,391 shares @ $0
07/22/2019 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 9,402 shares @ $0
Acquired 9,391 shares @ $0
07/12/2019 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 10,154 shares @ $0
Acquired 6,388 shares @ $0
05/15/2019 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Acquired 11,753 shares @ $0
04/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2019 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 173,000 shares @ $0
Granted 292,700 options to buy @ $26.89, valued at $7.9M
10/17/2018 4 Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Bought 40,000 shares @ $18, valued at $720k
Converted 29,946 shares @ $0
Converted 5,704 convertible preferred @ $0
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/04/2017 4 Chang David D (EVP, R&D, Chief Medical Off.) has filed a Form 4 on Kite Pharma, Inc.
Txns: Sold 691 shares @ $78.53, valued at $54.3k
Sold 3,939 shares @ $79.63, valued at $313.7k
Sold 2,424 shares @ $80.44, valued at $195k
Sold 3,549 shares @ $82, valued at $291k
Sold 8,697 shares @ $82.6, valued at $718.4k
Sold 700 shares @ $83.66, valued at $58.6k
Exercised 20,000 options to buy @ $6.89, valued at $137.8k
03/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/27/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
12/22/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy